ArticleJACC. Case reports2026
Transcatheter Tricuspid Valve Replacement in a Patient With Small Right Atrium and Multiple Device Leads.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reading TTVR Mechanically: Three Questions This Mini-Focus Helps Us Ask.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSevere tricuspid regurgitation (TR) in patients with small right atrial (RA) or right ventricular dimensions poses a significant challenge for transcatheter tricuspid valve replacement (TTVR). CASE SUMMARY: A 39-year-old woman with prior coronary artery bypass grafting, mitral valve replacement, and LMNA cardiomyopathy with a dual-chamber implantable cardioverter-defibrillator presented with torrential TR. She was deemed to be a poor surgical candidate, and TTVR with the EVOQUE system was aborted due to insufficient RA height. She underwent TTVR with the Laplace system. Imaging confirmed resolution of TR, and the patient had notable and sustained improvements in her functional capacity and quality of life at 6-month follow-up. DISCUSSION: This case demonstrates the feasibility of the Laplace TTVR system for treating severe TR in a patient with small RA/right ventricular size that precluded the use of currently available commercial TTVR devices. TAKE-HOME MESSAGE: Novel TTVR systems may provide additional options for treating TR in patients with challenging anatomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.